Youd have to be living under a rock to miss the explosion of the newest weight loss drugs, GLP-1 and GIP receptor agonists
One of the key members of the laboratory was Jens Rehfeld, a young Danish gastrointestinal researcher who gathered around him a dynamic circle of enthusiastic young doctors and doctoral students (figure 28) keen to research newly discovered gut peptides
Consistency is the foundation of metabolic health, and understanding the logic behind the dosing schedule is essential for achieving the best possible results
Orlistat (Xenical/Alli), a lipase inhibitor available on the NHS, typically produces mean weight loss of around 35% compared with placebo over 12 months, making it a modest option for many patients
Link Between Ozempic and Gastroparesis: Ozempic slows stomach emptying to help control blood sugar, but this can worsen or trigger gastroparesis in some patients
Navigating Health and Wellness: Insights on GLP-1 Medications, Thyroid Health, and Hormone Therapy In a recent podcast episode, McCall McPherson delves into a variety of health topics, focusing on GLP-1 medications, thyroid health, and hormone therapy
